42389-40-2 Usage
Description
2-(1H-benzimidazol-2-ylamino)-6-methylpyrimidin-4(1H)-one is a heterocyclic chemical compound with the molecular formula C13H11N5O. It features a benzimidazole group and a pyrimidine ring, and is recognized for its potential biological activity. 2-(1H-benzimidazol-2-ylamino)-6-methylpyrimidin-4(1H)-one has been the subject of research for its possible use as a pharmaceutical drug, demonstrating promising results in inhibiting specific enzymes and receptors within the body. Its distinctive structure and potential applications make it a compound of interest for further exploration in medicinal chemistry and pharmaceutical development.
Uses
Used in Pharmaceutical Development:
2-(1H-benzimidazol-2-ylamino)-6-methylpyrimidin-4(1H)-one is utilized as a candidate for drug development due to its ability to inhibit certain enzymes and receptors in the body. This makes it a valuable asset in the creation of new medications targeting specific biological pathways.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-(1H-benzimidazol-2-ylamino)-6-methylpyrimidin-4(1H)-one serves as a subject of study for understanding its potential interactions with biological systems. Its unique structure allows researchers to investigate its properties and how it can be harnessed for therapeutic purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 42389-40-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,3,8 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 42389-40:
(7*4)+(6*2)+(5*3)+(4*8)+(3*9)+(2*4)+(1*0)=122
122 % 10 = 2
So 42389-40-2 is a valid CAS Registry Number.
42389-40-2Relevant articles and documents
Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists
Aquino, Christopher J.,Ramanjulu, Joshi M.,Heyer, Dennis,Daniels, Alejandro J.,Palazzo, Fabio,Dezube, Milana
, p. 2691 - 2708 (2007/10/03)
A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed.
